1974•Acta Obstetricia Et Gynecologica ScandinavicaRequires access

Malignant and Pseudomalignant Hyperplasia Adenomatosa of the Endometrium in Postmenopausal Women Treated with Oestrogen

Erling Østergaard

Open publisher page 9 citations

Abstract

Abstract. Malignant and Pseudomalignant Hyperplasia of the Endometrium in Postmenopausal Women treated with Oestrogens. In a two year period 81 patients were admitted because of metrorrhagia related to postmenopausel oestrogen treatment. Diagnostic curettage disclosed various degree of oestrogenic stimulation of the endometrium from slightly proliferative to cyclic glandular hyperplasia, which was observed in no less than 29 cases. The causal treatment was in the majority of cases repeated injections of oestradiolbenzoate or continuous intake of oestrogen tablets. In 5 cases the histological diagnosis was endometrial hyperplasia suspect for malignancy. After a period of observation of 6 weeks without oestrogens a new curettage was done. in 3 of the cases the diagnosis of malignant hyperplasia was maintained and a subsequent hysterectomy substantiaited the diagnose of endometrial carcinoma. in 2 cases an atrophic climacteric pattern of the endometrium was found at the second curettage. These pseudomalignant cases have been followed now for up to three years without any signs of uterine malignancy. Two malignant cases and one pseudomalignant case are reported in detail with the relevant microphotos. It is not possible morphologically to discriminate malignant from pseudomalignant hyperplasia. a period of observation without oestrogens before the final diagnostic curettage is necessary for this differential diagnosis.

About this research paper

What this paper is about

Abstract. Malignant and Pseudomalignant Hyperplasia of the Endometrium in Postmenopausal Women treated with Oestrogens. In a two year period 81 patients were admitted because of metrorrhagia related to postmenopausel oestrogen treatment. Diagnostic curettage disclosed various degree of oestrogenic stimulation of the endometrium from slightly proliferative to cyclic glandular hyperplasia, which was observed in no less than 29 cases. The causal treatment was in the majority of cases repeated injections of oestradiolbenzoate or continuous intake of oestrogen tablets. In 5 cases the histological diagnosis was endometrial hyperplasia suspect for malignancy. After a period of observation of 6 weeks without oestrogens a new curettage was done. in 3 of the cases the diagnosis of malignant hyperplasia was maintained and a subsequent hysterectomy substantiaited the diagnose of endometrial carcinoma. in 2 cases an atrophic climacteric pattern of the endometrium was found at the second curettage. These pseudomalignant cases have been followed now for up to three years without any signs of uterine malignancy. Two malignant cases and one pseudomalignant case are reported in detail with the relevant microphotos. It is not possible morphologically to discriminate malignant from pseudomalignant hyperplasia. a period of observation without oestrogens before the final diagnostic curettage is necessary for this differential diagnosis.

Why it matters

OpenAlex reports 9 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Abstract. Malignant and Pseudomalignant Hyperplasia of the Endometrium in Postmenopausal Women treated with Oestrogens. In a two year period 81 patients were admitted because of metrorrhagia related to postmenopausel oestrogen treatment. Diagnostic curettage disclosed various degree of oestrogenic stimulation of the endometrium from slightly proliferative to cyclic glandular hyperplasia, which was observed in no less than 29 cases. The causal treatment was in the majority of cases repeated injections of oestradiolbenzoate or continuous intake of oestrogen tablets. In 5 cases the histological diagnosis was endometrial hyperplasia suspect for malignancy. After a period of observation of 6 weeks without oestrogens a new curettage was done. in 3 of the cases the diagnosis of malignant hyperplasia was maintained and a subsequent hysterectomy substantiaited the diagnose of endometrial carcinoma. in 2 cases an atrophic climacteric pattern of the endometrium was found at the second curettage. These pseudomalignant cases have been followed now for up to three years without any signs of uterine malignancy. Two malignant cases and one pseudomalignant case are reported in detail with the relevant microphotos. It is not possible morphologically to discriminate malignant from pseudomalignant hyperplasia. a period of observation without oestrogens before the final diagnostic curettage is necessary for this differential diagnosis.

Key concepts: Medicine, Curettage, Endometrial hyperplasia, Endometrium, Hyperplasia, Malignancy, Atypical hyperplasia, Gynecology

Related papers

Back to paper searchBrowse research topicsOriginal source
Malignant and Pseudomalignant Hyperplasia Adenomatosa of the Endometrium in Postmenopausal Women Treated with Oestrogen — Research Paper | ScholarLens